Research Progress on D-Allulose: A Review of Physiological Functions and Enzymatic Biotransformation

If you formulate reduced-sugar products, D-allulose deserves your attention. A 2021 review in Foods (10(9), 2186) pulled the research together. It shows why ingredient buyers should treat D-allulose as more than just a sugar substitute.

A sugar substitute with a bigger job

D-allulose already has real commercial footing. The review describes it as a food ingredient and a dietary supplement. That dual role matters. You can use it in products, and consumers can take it directly. The review also makes a stronger point: D-allulose does not just add sweetness. It carries physiological functions.

Those functions are the core of the paper. The authors focused on three areas. First, physiological effects. Second, enzymatic biotransformation. Third, production processes.

The physiological section covers metabolic health. D-allulose can improve insulin resistance. It has anti-obesity properties. It helps regulate glucolipid metabolism. For formulators, that opens up product concepts beyond sugar reduction.

What the study covered

This was a review, not a new clinical trial. The authors looked at existing evidence and organized it around production and function. That structure makes the paper useful for people who need both science and supply-chain context.

The enzymatic biotransformation section matters for buyers. D-allulose production depends on enzyme-driven conversion. The review lays out the biotransformation strategies and the process steps around them. For an ingredient buyer, that is a reminder: production technology drives cost, quality, and availability.

The regulatory picture is also in the review. D-allulose has received FDA GRAS certification. It has been approved for use in many foods and dietary supplements. That gives you a clear path to product development.

Key findings at a glance

Area	Finding from the review
Insulin resistance	D-allulose improves insulin resistance
Anti-obesity	D-allulose has anti-obesity effects
Glucolipid metabolism	D-allulose regulates glucose and lipid metabolism
Regulatory status	FDA GRAS; approved for many foods and supplements

What this means for manufacturers

Start with regulatory status. GRAS certification removes a major hurdle. You can source D-allulose and formulate with it now. That is not true for every emerging sweetener.

The functional benefits separate D-allulose from standard sugar replacers. It can support metabolic wellness positions in foods and supplements. That is valuable in product categories aimed at blood sugar, weight management, or overall metabolic health.

Production should shape your buying decisions. The review’s emphasis on enzymatic biotransformation tells you where the real cost sits. Enzyme efficiency and downstream processing will determine price and quality. Ask suppliers about their enzyme systems. Ask about yield. Ask about purification. Those details separate reliable suppliers from the rest.

For formulators, the published science supports pilot trials. Test D-allulose in your target application. Measure sweetness, texture, and stability. Use the review as a starting point, not a substitute for your own bench work.

Frequently asked questions

Does D-allulose have FDA GRAS status? Yes. The review confirms that D-allulose has received FDA GRAS certification and is approved as an ingredient in many foods and dietary supplements.

What physiological functions does the review highlight? It highlights improved insulin resistance, anti-obesity effects, and regulation of glucolipid metabolism.

Why does the review focus on enzymatic biotransformation? Because enzyme-driven conversion is central to D-allulose production. The review covers biotransformation routes and the production processes needed to make the ingredient available at commercial scale.

The 2021 Foods review gives formulators and buyers a clear snapshot of D-allulose. It has regulatory approval. It has a growing body of physiological research. It has a production pathway that can scale. That combination is hard to ignore.